Join moderator Emily Wallack as we hear how Mark, a patient living with moderate-to-severe plaque psoriasis, rediscovered self-love after finding ILUMYA® (tildrakizumab-asmn), a treatment that he receives for little to no cost with coverage under Medicare Part B with a supplement. Dermatologist Dr. Omar Noor also joins to offer insights on diagnosing and treating psoriasis. This episode is sponsored by Sun Pharma. To view important safety information: ilumya.com

Clinical studies are not always representative of the actual patient population, which can limit our understanding of patient outcomes. Join NPF moderator Takieyah Mathis as we hear from LaShell Robinson and Marygrace Corral with Takeda on why it's so important to ensure diversity in clinical research, what they are doing to improve racial diversity in their clinical studies, and how you can support these efforts. This episode is sponsored by Takeda.

On this episode, we'll talk about redefining remission - when a patient and their healthcare practitioner work together to discuss and create a personalized approach to psoriatic arthritis care with moderator Jeff Brown and guests Noelia Ferreyra, a patient advocate living with psoriatic disease, and Dr. Saakshi Khattri, a dermatologist/rheumatologist in New York who serves on the medical board of the NPF. This podcast is sponsored by UCB.

Plaque psoriasis is a lifelong disease with no cure, but living well with clearer skin is possible. This World Psoriasis Day dermatologist/rheumatologist Dr. Alice Gottlieb discusses the benefits of a once-daily, steroid-free prescription treatment for adults with plaque psoriasis. Discover how this effective, safe and well-tolerated option can help manage plaque psoriasis, even on affected sensitive areas. This episode is sponsored by Dermavant Sciences.

In 2025 key changes impact Medicare beneficiaries. Listen as Jason Harris, NPF VP of Government Relations & Advocacy and dermatologist/rheumatologist Dr. Alice Gottlieb with the Dept. of Dermatology, Icahn School of Medicine at Mount Sinai, discuss issues and tips for transitioning to Medicare health coverage, the $2,000 expense cap, and smoothing expenses. This episode is made possible with support from Sun Pharma and Novartis.

Over 20 years ago biologics were introduced for psoriasis and PsA. Since then even more targeted treatments have been introduced. Listen as dermatologist Dr. Steven Feldman from Wake Forest University School of Medicine, shares his perspectives on the latest treatments, resident memory T-cells, and what's to come (such as an oral IL-23 agent) with moderator Max Blitstein. This episode is provided with support from Bristol Myers Squibb.

Patient advocate Alisha Bridges and dermatologist Dr. Mona Shahriari discuss a study dedicated to people of all skin tones who have moderate to severe plaque psoriasis. Dr. Shahriari also shares her experience guiding people with skin of color as they navigate their psoriasis journey. This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in the podcast.

Psoriasis is not just a skin disease. It's about inflammation. Listen as dermatologist Dr. Chesahna Kindred at Kindred Hair and Skin Center, and moderator Michelle Zimmerman discuss related diseases that people with psoriasis are at risk of developing like uveitis, heart disease, IBD, PsA and more. Hear what screenings and actions you can take to control what you can. For our episode sponsors please check our web page at psoriasis.org/watch-and-listen/.